In this study, 9 patients with primary hypercholesterolemia were treated with pravastatin. They received a daily dose of 20 mg for 12 weeks. Results showed a significant reduction in total and LDL cholesterol, whereas no significant difference was observed in HDL and triglyceride levels after treatment. No adverse effects were observed.

Marnini, P., Bonfanti, P., Piantanida, E., Venco, A. (1994). Efficacy and tolerability of pravastatin for short-term management of primary hypercholesterolaemia [EFFICACIA E TOLLERABILITA DELLA PRAVASTATINA NEL TRATTAMENTO A BREVE TERMINE DELLE IPERCOLESTEROLEMIE PRIMARIE]. LA CLINICA TERAPEUTICA, 144(1), 49-53.

Efficacy and tolerability of pravastatin for short-term management of primary hypercholesterolaemia [EFFICACIA E TOLLERABILITA DELLA PRAVASTATINA NEL TRATTAMENTO A BREVE TERMINE DELLE IPERCOLESTEROLEMIE PRIMARIE]

Bonfanti, P;
1994

Abstract

In this study, 9 patients with primary hypercholesterolemia were treated with pravastatin. They received a daily dose of 20 mg for 12 weeks. Results showed a significant reduction in total and LDL cholesterol, whereas no significant difference was observed in HDL and triglyceride levels after treatment. No adverse effects were observed.
Articolo in rivista - Articolo scientifico
hypercholesterolemia; pravastatin;
Italian
1994
144
1
49
53
none
Marnini, P., Bonfanti, P., Piantanida, E., Venco, A. (1994). Efficacy and tolerability of pravastatin for short-term management of primary hypercholesterolaemia [EFFICACIA E TOLLERABILITA DELLA PRAVASTATINA NEL TRATTAMENTO A BREVE TERMINE DELLE IPERCOLESTEROLEMIE PRIMARIE]. LA CLINICA TERAPEUTICA, 144(1), 49-53.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/360968
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
Social impact